Gittenberger-De Groot et al. used immunohistochemistry to confirm an overexpression of COL6A1 and COL6A2 in the hearts of trisomy 21 fetuses, suggesting their potential involvement in the development of congenital cardiac abnormalities seen in DS patients [98]. This evidence concerns the gene COL6A2 and Dravet syndrome.